Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Germing

Showing results (1-10 of 339) with videos related to

Pageof 34
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|June 29, 2006
[Myelodysplastic syndromes--new treatment options]Ulrich Germing
Deutsches Arzteblatt International|March 14, 2014
In replyUlrich Germing
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 1, 2004
[Refractory anemia (RA) and refractory cytopenia with multilineage dysplasia (RCMD) in WHO classification: comparison between Japanese and German cases]Akira Matsuda, Ulrich Germing
Cancer Treatment Reviews|October 28, 2008
Emerging treatment strategies for acute myeloid leukemia (AML) in the elderlyAndrea Kuendgen, Ulrich Germing
Leukemia Research|April 23, 2013
How to treat patients with CMML?Ulrich Germing, Judith Neukirchen
Haematologica|September 13, 2005
Perspectives in the prognostication of myelodysplastic syndromesUlrich Germing, Andrea Kuendgen
Frontiers in Oncology|March 27, 2023
Editorial: Hybrid or mixed myelodyplastic/myeloproliferative disorders: Current trends in diagnosis and treatmentArgiris Symeonidis, Ulrich Germing
Leukemia Research|September 18, 2012
Prognostic scoring systems in MDSUlrich Germing, Andrea Kündgen
Leukemia Research|April 25, 2006
Differences in epidemiology of MDS between Western and Eastern countries: Ethnic differences or environmental influence?Andrea Kuendgen, Akira Matsuda, Ulrich Germing
European Journal of Haematology|October 16, 2012
Correlation between the low marrow blast cutpoint and WHO classification for myelodysplastic syndromesAkira Matsuda, Ulrich Germing, Yasushi Miyazaki
Pageof 34

Showing results (1-10 of 339) with videos related to

Sort By:
Pageof 34
Medizinische Klinik (Munich, Germany : 1983)|June 29, 2006
[Myelodysplastic syndromes--new treatment options]Ulrich Germing
Deutsches Arzteblatt International|March 14, 2014
In replyUlrich Germing
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 1, 2004
[Refractory anemia (RA) and refractory cytopenia with multilineage dysplasia (RCMD) in WHO classification: comparison between Japanese and German cases]Akira Matsuda, Ulrich Germing
Cancer Treatment Reviews|October 28, 2008
Emerging treatment strategies for acute myeloid leukemia (AML) in the elderlyAndrea Kuendgen, Ulrich Germing
Leukemia Research|April 23, 2013
How to treat patients with CMML?Ulrich Germing, Judith Neukirchen
Haematologica|September 13, 2005
Perspectives in the prognostication of myelodysplastic syndromesUlrich Germing, Andrea Kuendgen
Frontiers in Oncology|March 27, 2023
Editorial: Hybrid or mixed myelodyplastic/myeloproliferative disorders: Current trends in diagnosis and treatmentArgiris Symeonidis, Ulrich Germing
Leukemia Research|September 18, 2012
Prognostic scoring systems in MDSUlrich Germing, Andrea Kündgen
Leukemia Research|April 25, 2006
Differences in epidemiology of MDS between Western and Eastern countries: Ethnic differences or environmental influence?Andrea Kuendgen, Akira Matsuda, Ulrich Germing
European Journal of Haematology|October 16, 2012
Correlation between the low marrow blast cutpoint and WHO classification for myelodysplastic syndromesAkira Matsuda, Ulrich Germing, Yasushi Miyazaki
Pageof 34